
Azacitidine Seacross 25 mg/mL Powder for Suspension for Injection is an anticancer medicine used to treat certain blood cancers and bone marrow disorders, including myelodysplastic syndromes (MDS), acute myeloid leukaemia (AML), and chronic myelomonocytic leukaemia (CML). It helps slow the growth of abnormal blood cells and supports the production of healthy blood cells. The medicine is administered by a healthcare professional.
| Generic name | Azacitidine Seacross |
| Strength | 25 mg |
| Manufacturer | Seacross Pharmaceuticals |
| Package size | 1 vial |
| Used for | Myelodysplastic syndromes (MDS), acute myeloid leukaemia (AML), and chronic myelomonocytic leukaemia (CML) |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Azacitidine is a hypomethylating agent. It works by changing abnormal DNA methylation patterns in cancer cells, restoring normal gene activity and slowing the growth of abnormal blood cells. This helps the bone marrow produce healthier blood cells and improves blood counts over time.
Dr. Neeru Mehta holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. Her interests include cancer treatments, monitoring treatment progress, managing side effects and supportive care.